ArticleCost effectiveness and resource allocation : C/E2026

Cost-effectiveness analysis of PET-guided BrECADD with chemotherapy in advanced-stage, classical Hodgkin lymphoma.

Guihao Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.